Announce Date | 02/28/2025 |
EPS Normalized Actual | $0.54 (Beat by $0.19) |
EPS GAAP Actual | $0.54 (Beat by $0.19) |
Revenue Actual | $2.962B |
Revenue Surprise | Beat by $2962M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 2.54 | 3.96 | 2.39717 | 2.68859 | 1 |
Dec 2027 | 2.125 | 4.73 | 2.00551 | 2.24931 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.38 | 0.38 | 2.962B | -0.2% | 2962M |
FQ3 2024 (Sep 2024) | 0.61 | 0.61 | 3.289B | -4.41% | 3289M |
FQ3 2023 (Sep 2023) | 0.34 | 0.34 | 3.434B | -5.62% | 3434M |
FQ4 2023 (Dec 2023) | -0.15 | -0.15 | 2.968B | -3.1% | 2968M |
FQ1 2024 (Mar 2024) | 0.62 | 0.62 | 3.085B | -4.99% | 3085M |
FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 2.942B | -2.89% | 2942M |
FQ2 2023 (Jun 2023) | 0.5 | 0.5 | 3.027B | -1.68% | 3027M |
FQ1 2023 (Mar 2023) | 712 | 712 | 3.239B | 100% | 3239M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Oct 2028) | 0.9051 | -- | 0.8938 | 0.91464 | 1 |
FQ3 2028 (Jul 2028) | 0.3188 | -- | 0.31482 | 0.32216 | 1 |
FQ2 2028 (Jun 2028) | 0.3188 | -- | 0.31593 | 0.32205 | 1 |
FQ1 2028 (Mar 2028) | 0.3177 | -- | 0.31484 | 0.32094 | 1 |
FQ4 2027 (Oct 2027) | 0.7909 | -- | 0.78103 | 0.79923 | 1 |
FQ3 2027 (Jul 2027) | 0.2786 | -- | 0.27512 | 0.28154 | 1 |
FQ2 2027 (Jun 2027) | 0.2786 | -- | 0.27609 | 0.28144 | 1 |
FQ1 2027 (Mar 2027) | 0.2776 | -- | 0.2751 | 0.28043 | 1 |
FQ4 2026 (Oct 2026) | 0.7178 | -- | 0.70884 | 0.72536 | 0 |
FQ3 2026 (Sep 2026) | 0.7178 | -- | 0.70502 | 0.73159 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2028 (Oct 2028) | 4B | -- | 3.96B | 4.03B | 0 |
FQ3 2028 (Jul 2028) | 3.94B | -- | 3.91B | 3.98B | 0 |
FQ2 2028 (Jun 2028) | 3.85B | -- | 3.82B | 3.88B | 0 |
FQ1 2028 (Mar 2028) | 3.79B | -- | 3.77B | 3.82B | 0 |
FQ4 2027 (Oct 2027) | 3.78B | -- | 3.74B | 3.81B | 2 |
FQ3 2027 (Jul 2027) | 3.72B | -- | 3.69B | 3.75B | 2 |
FQ2 2027 (Jun 2027) | 3.63B | -- | 3.61B | 3.66B | 1 |
FQ1 2027 (Mar 2027) | 3.58B | -- | 3.56B | 3.61B | 1 |
FQ4 2026 (Oct 2026) | 3.56B | -- | 3.53B | 3.59B | 1 |
FQ3 2026 (Sep 2026) | 11.13B | -- | 10.98B | 11.29B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.38 | 0.38 | 100% | |
FQ3 2024 (Sep 2024) | 0.61 | 0.61 | 100% | |
FQ3 2023 (Sep 2023) | 0.34 | 0.34 | 100% | |
FQ4 2023 (Dec 2023) | -0.15 | -0.15 | 100% | |
FQ1 2024 (Mar 2024) | 0.62 | 0.62 | 100% | |
FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 100% | |
FQ2 2023 (Jun 2023) | 0.5 | 0.5 | 100% | |
FQ1 2023 (Mar 2023) | 712 | 712 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $2.96B | $2962M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.29B | $3289M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.43B | $3434M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.97B | $2968M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.09B | $3085M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.94B | $2942M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.03B | $3027M | 100% |
FQ1 2023 (Mar 2023) | $0B | $3.24B | $3239M | 100% |